Abstract: Systems and methods are disclosed for adjusting the correlated color temperature (CCT) reflecting the warmth of emitted light for a non-tungsten based lighting device as intensity of the lighting device is modified. The CCT of the non-tungsten based lighting device is determined at a lighting control device that can provide fixture-dependent driver levels to various lighting devices of varying types. A lighting controller engine can determine a white component color temperature value based on a desired intensity level and a default CCT value received via a user interface of the lighting control device. The lighting control device can determine the driver levels for controlling characteristics of light emitted from the non-tungsten based lighting device based on the white component color temperature value and a user defined color level. The lighting control device can scale the white component color temperature to reflect variations of warmth as the intensity level is adjusted.

Abstract: A lighting controller provides a user interface module and a lighting controller engine. The user interface module allows a user to specify settings for one or more lighting fixtures using descriptive, absolute or relative values, which the lighting controller engine translates into fixture-dependent values before sending them to the lighting fixtures. The user interface module also provides context-based displays and context-based controls.

Abstract: A lighting controller provides a user interface module and a lighting controller engine. The user interface module allows a user to specify settings for one or more lighting fixtures using descriptive, absolute or relative values, which the lighting controller engine translates into fixture-dependent values before sending them to the lighting fixtures. The user interface module also provides context-based displays and context-based controls.

Abstract: A pharmaceutical delivery system enabling the oral transmucosal administration of active pharmaceutical agents in a situation where rapid transmucosal administration is preferred to prevent the delay and decomposition of the agents in passing through the intestinal tract. The delivery system comprises a supportive substrate with bilateral lingual vestibular flanges connected at the anterior midline to form a ‘U’ like shape for fitting in the potential space of the bilateral lingual vestibules, and further comprising a handle or tab for holding the device in the mouth of a patient with altered consciousness to prevent aspiration or premature swallowing. The pharmaceutical dosage-form is formulated and shaped to contact the mucosal tissues and may include mucoadhesive compounds, retentive compounds, and/or additional payload enhancers, such as permeation enhancers and flavor enhancers.

Abstract: A pharmaceutical delivery system enabling the oral transmucosal administration of active pharmaceutical agents in a situation where rapid transmucosal administration is preferred to prevent the delay and decomposition of the agents in passing through the intestinal tract. The delivery system comprises a supportive substrate with bilateral lingual vestibular flanges connected at the anterior midline to form a ‘U’ like shape for fitting in the potential space of the bilateral lingual vestibules, and further comprising a handle or tab for holding the device in the mouth of a patient with altered consciousness to prevent aspiration or premature swallowing. The pharmaceutical dosage-form is formulated and shaped to contact the mucosal tissues and may include mucoadhesive compounds, retentive compounds, and/or additional payload enhancers, such as permeation enhancers and flavor enhancers.

Abstract: A personal air-filtration device directing filtered air at the face without the use of a mask or a mouthpiece is described. The inventive device provides filtered air to the user without obstructing the user's mouth, thus allowing the user to talk and consume food and/or water while in operation.

Abstract: A personal air-filtration device directing filtered air at the face without the use of a mask or a mouthpiece is described. The inventive device provides filtered air to the user without obstructing the user's mouth, thus allowing the user to talk and consume food and/or water while in operation.